Novel scale correlates children’s snacking behaviors with external food cues

One in four preschool-age children in the U.S. have overweight or obesity, putting them at risk for multiple chronic health problems including cancer. Early and consistent exposure to such food cues may promote conditioned eating, where the cue itself becomes a signal to eat. Children may then learn to eat by exposure to external cues rather than listing to their internal, biological signals of hunger.

Psychometric scales for adults and children ages 7-12 have previously been created to measure responses to external food cues such as desire to eat when walking past a candy store or temptation when food is being prepared. However, to date, no scale exists that specifically addresses responsiveness to external cues, such as visual, environmental or social cues, in contemporary preschool-age children.

A Dartmouth research team led by Jennifer Emond, MS, PhD aimed to extend previous research and develop a brief, parent-reported scale to measure external food cue responsiveness for preschool-age children that could be employed easily in their natural environments. “A scale to specifically measure responsiveness to external foods is important to understand how aspects of the current obesogenic environment, including exposure to food marketing, may impact a young child’s obesity risk,” says Emond. Their study, “Measurement of external food cue responsiveness in preschool-age children: Preliminary evidence for the use of the external food cue responsiveness scale” is newly published in the journal, Appetite.

The study was conducted in two stages. Eight focus groups of parents of 2-5-year-old children informed an initial pool of 33 items to be included in an external food cue responsiveness scale for preschool-age children. Items included cues such as passing by restaurants, waiting in check-out aisles at grocery stores, seeing others eat, and hearing food wrappers. The items were phrased to enable parents to rate how well each behavior described their own child’s behaviors and were scored on a scale of “rarely” to “a lot.” These items were then distributed in an online survey to 456 parents recruited nationally via social media. Statistical analyses were applied and the list was reduced to the final nine items comprising the new External Food Cue Responsiveness Scale. Items include branded packaging, product placement, social influence and restaurant logos, which are all aspects of food marketing that impact young children’s eating behaviors yet have not been operationalized into an easy-to-administer scale.

Findings suggest that this novel scale effectively captures children’s behavioral responsiveness to external food cues and, in particular, cues related to food marketing. The team sought to validate the usefulness of this new scale under free-living conditions by correlating scores with an existing validated scale of food responsivity. As expected, external food cue responsiveness was positively associated with overeating behaviors. Using the common cued-snacking behavior of eating while watching TV, they also found that external food cue responsiveness was greater among children with, versus without, usual TV advertisement exposure.

For the next steps, the research team will assess the validity of the novel scale against laboratory measures of cued-eating in preschool-age children. “This line of research is important for identifying how aspects of a young child’s natural environment, including obesogenic features, may impact eating behaviors during this critical stage of development,” says Emond.

Story Source:

Materials provided by Dartmouth-Hitchcock Medical Center. Note: Content may be edited for style and length.

Share Button

Species facing climate change could find help in odd place: Urban environments

When it comes to wildlife conservation efforts, urban environments could be far more helpful than we think, according to new research. A study published today in Ecology shows that animals move faster through ‘low quality’ habitats — evidence that could change the way conservationists think about managing landscapes to help species move in response to climate change. In light of the recent UN report indicating that 1 million species are threatened with extinction, the study provides a framework for definitive action to help preserve many species at risk. The work was carried out by researchers at Tufts University, University of Liverpool, Washington State University and the University of Ottawa.

For landscapes to facilitate range expansion, there is a balance to be struck between promoting movement with low-quality habitat (places where a species can survive, but does not have all the resources it needs to complete its life cycle) and promoting population growth with high-quality habitat. They conclude that low-quality habitats that meet a minimum standard could actually provide a benefit as conduits for movement.

The underlying behaviour that explains this surprising result is that when animals find themselves in an inhospitable area they tend to make longer and straighter movements. As long as they do not die in this area, their arrival at another breeding area will tend to be quicker. The researchers used data from 78 species in 70 studies to show that in 73 percent of cases, animals moved faster through ‘lower-quality’ habitats. To illustrate what this principle means on the ground, the team used mathematical models to calculate rates of range expansion across a variety of landscapes for an exemplar species — the Baltimore checkerspot butterfly. They showed that range expansion is fastest through landscapes composed of around 15 percent high-quality habitat and 85 percent unsuitable habitat.

“At landscape scales, 15% high-quality habitat is still more than currently exists in most ecosystems. Nonetheless, our findings point to the potential of using suburban and even urban greenspace as underappreciated areas that could facilitate range shifts, if green spaces such as lawns were converted to native plant gardens, which have high conservation potential for insects and other wildlife species,” said lead author Elizabeth Crone, a professor of biology at Tufts University.

Jenny Hodgson, co-author of the study and lecturer in evolution, ecology and behaviour at the University of Liverpool added: “This could offer a new perspective of flexibility for landscape planners: they needn’t worry if they can’t create unbroken tracts of high-quality wildlife habitat, instead they can create strategic ‘stepping stones’ in urban and agricultural areas. However, the stepping stones need to provide resources for breeding, not just temporary food resources.”

The researchers hope their study will make designers of city and suburban environments start to think differently about their approach, by providing a starting point to assess the consequences of landscape structure in the management of wildlife, regardless of whether the goal is to enhance or restrict the potential for range expansion.

“Nearly all high-profile studies about biodiversity conservation have focused on documenting the patterns of species habitat use and movement. We feel that more insights are gained by considering the mechanisms behind these patterns,” said co-author Cheryl Schultz, professor of conservation biology at Washington State University. “In this case, our discovery that lower quality habitats assist species movement to better habitats sets up a more realistic and achievable objective for urban landscapers, and provides an important complement to conservation efforts focused on preserving large tracts of natural areas and high-quality habitat.”

Also contributing to the study were Frithjof Lutscher, professor at University of Ottawa, who provided the population dynamics model and its analysis, and Leone Brown, research associate at Tufts University.

This work was funded by a Department of Defense Strategic Environmental Research and Development Program Award to EEC and CBS (RC-2119) and by an NSERC Discovery Grant to FL (RGPIN-2016-04795).

Story Source:

Materials provided by Tufts University. Note: Content may be edited for style and length.

Share Button

Health24.com | A father’s death at 37 reveals a hidden history of cholesterol

Carl Korfmacher was nine years old when his father, Ron, returned from the Mayo Clinic for a check-up in the early 1970s.

Though he was lean and seemed fit, his father had been experiencing chest pains and coughing. His cholesterol was high. Plus, he was a heavy smoker. As he arrived home that day, July Fourth, his 37th birthday, Ron Korfmacher assured his family everything was going to be fine.

Elevated cholesterol levels

The next day, at his belated birthday celebration, amid the sound of firecrackers, he fell over at a picnic table. He struggled to breathe. Then, he died of a heart attack.

The man young Carl so looked up to was gone. He was buried a few days later, on Carl’s 10th birthday.

“He was a very wonderful and unique individual,” Carl recalled. “They couldn’t believe that a man that young could have heart disease.”

A few months later, Carl’s mother, Louise, had her children’s cholesterol checked. It was a wise decision. He and his brothers had elevated cholesterol levels, like their father.

Cholesterol is a waxy substance in the blood that can build up in arteries and lead to atherosclerosis, or narrowing of the arteries, which can eventually result in a heart attack or stroke. Other factors, such as high blood pressure, diabetes and smoking, compound the risk.

Cholesterol-lowering medicine wasn’t readily available then, so Louise made sure the family adhered to a healthy diet aimed at combatting high cholesterol.

Family history and other conditions

“She was pretty adamant and very careful,” Carl said. They ate very little red meat, used egg substitutes and drank dehydrated skim milk because that’s what was available. “We hated that!”

But he would come to cherish his mother’s insistence on safeguarding their health.

About 20 years ago, Carl began taking statin drugs, a type of cholesterol-lowering medication that can help reduce the risk of heart attack and stroke. At the time, his overall cholesterol was around 270 to 280 mg/dL (milligrams per decilitre) and his ratios of HDL, or “good” cholesterol, and LDL, or “bad cholesterol,” weren’t in a desirable range.

A variety of studies have suggested the optimal level of LDL in adults is less than 100 mg/dL. Recent research has found that those with LDL of 160 or higher, even with no history of heart disease or diabetes, had a 70% to 90% higher risk of dying from cardiovascular disease compared with those who had LDL below 100.

New cholesterol guidelines published in the journal Circulation advised health care providers to look at family history and other health conditions in assessing a patient’s heart disease risk.

“Family history of high cholesterol suggests there may be a genetic cholesterol disorder,” said Dr Sarah de Ferranti, chief of outpatient cardiology and director of preventive cardiology at Boston Children’s Hospital. Cholesterol screening can identify the one in 250 people who have a genetic cholesterol disorder, she said.

Familial hypercholesterolaemia

If there’s a family history of early heart disease or high cholesterol, children can reasonably be screened as young as age two, with a repeat screening every three to five years, said de Ferranti, a member of the committee that wrote the cholesterol guidelines issued by the American College of Cardiology and American Heart Association. If a child has other cardiovascular risk factors, such as hypertension, obesity or diabetes, that can potentially prompt a cholesterol check, she said.

For otherwise healthy children without a concerning family history, it may be reasonable to do routine screening between ages nine and 11 and again between 17 and 21.

At the urging of his mother, Carl’s two sons underwent cholesterol screening during routine physicals when they were younger. They, too, had elevated cholesterol levels.

Doctors diagnosed Carl and his boys with familial hypercholesterolaemia, an inherited condition of high cholesterol associated with a significant increased risk of early heart attack.

Today, Carl, 55, and his sons Henry, 18, and Owin, 14, keep their cholesterol under control through statins, a healthy diet and exercise. His wife, Krista, stays active, too, encouraging physical activity as a family way of life.

“I think we’re a good example for our boys,” said Carl, who lives with his family in Evansville, Wisconsin. “As parents, we try to instil it as a culture: We are not obese people. We work out. We are exercisers. That’s who we are.”

Carl and Krista encourage their sons to think about how to make good health decisions on their own. Their message for others, Carl said, is: “Stay on top of it. No news is not good news – get checked and tested. Learn about a healthy lifestyle and live it. It won’t only benefit your heart, but the rest of your life in so many ways.”

Image credit: iStock

Share Button

Health24.com | Cannabidiol has many uses – and may even lower stress

You would have to be living in a cave to have missed the CBD (cannabidiol) craze that is sweeping across America: New products are cramming store shelves as the market explodes for what many Americans believe to be a miracle cure-all.

Everything from oils to gummies to pills, creams and ointments are now for sale at supermarkets and specialty chains. You can even get massages infused with CBD, or cosmetics laced with the drug.

A ‘flood’ of products

All of these products contain cannabidiol but not THC, the ingredient in pot that provides a “high”. But what do scientists really know about the health benefits and risks of CBD?

Precious little, experts say, and consumers should take care that they aren’t wasting their money.

“You have a flood of CBD products that are coming from hemp that are going out onto the market, and you’ve got all sorts of claims being made about those from people are trying to sell them,” said Timothy Welty, chair of the department of clinical sciences at Drake University’s College of Pharmacy and Health Sciences, in Des Moines, Iowa.

The flood of CBD products has become so overwhelming that the US Food and Drug Administration recently stepped into the fray.

The agency has whipped out a flurry of warning letters to companies marketing CBD products, telling them to stop making unfounded health claims for the substance.

Companies have falsely claimed that CBD can stop cancer cells, slow the progression of Alzheimer’s disease, ease nerve pain and fibromyalgia, and curb withdrawal symptoms for people undergoing substance abuse treatment, the FDA letters state.

What started the craze?

The agency will hold a public hearing regarding CBD products and their safety, and it has formed a working group to consider new laws and regulations to govern this Wild West market.

CBD products have swamped the market not because of any new medical evidence, but because of a change in federal law, Welty noted.

Late last year, Congress passed a farm bill that lifted a decades-old ban on growing hemp. As long as the plant contains less than 0.3% THC, hemp can be grown legally anywhere in the United States by licensed farmers.

The bill specifically said the US Drug Enforcement Agency cannot regulate hemp products like CBD, Welty said. So, it’s now up to the FDA to regulate the CBD craze.

The body contains a system of receptors that respond to the compounds in marijuana, including both THC and CBD, noted Dr David Copenhaver, director of cancer pain management and supportive care for the University of California, Davis Health Center.

Because of this, researchers have been highly interested in the potential benefits of CBD regarding a number of different health problems.

Potential to treat anxiety disorder

To date, there’s only one use for CBD that has significant scientific evidence behind it – curbing the symptoms of rare forms of epilepsy.

The FDA last year approved the drug Epidiolex to treat two forms of childhood epilepsy. The medical evidence has shown that the highly purified CBD in Epidiolex can ease seizures.

For the rest of CBD’s potential uses, there is simply too little evidence to make a firm conclusion.

The next potential medical use for CBD could be for the symptoms of anxiety disorder, said Welty and Yasmin Hurd, chair of translational neuroscience and director of the Addiction Institute at Mount Sinai.

Clinical trials suggest that CBD could help treat anxiety, but Welty feels there needs to be more study. Hurd is slightly more convinced, but agrees more study is needed.

Other uses

“There is published evidence that CBD does decrease anxiety,” Hurd said. “That’s another indication where I can say I can believe the data; however, we still don’t know the dosing regimen that would be effective for anxiety. Those are studies that are ongoing.”

Other uses – as an anti-inflammatory, an aid for substance withdrawal, a sleep aid, a pain reliever – haven’t been conclusively proven.

In some cases, the evidence runs counter to what people might suspect.

There’s not much reason to believe CBD would be an effective means of pain relief, said Dr Ajay Wasan, vice chair for pain medicine at the University of Pittsburgh Medical Center.

“If you think of it as a medicine, it would be a weak analgesic,” Wasan said. “It’s really the THC component of medical marijuana which is the compound that gives you pain relief.”

Possibility of harm

CBD might actually make the eye disease glaucoma worse, according to a study published last December in the journal Investigative Ophthalmology & Visual Science.

Researchers found that CBD eye drops increased ocular pressure in mice, even as THC appeared to reduce pressure – which might explain why medical marijuana has had mixed results when it comes to studies on glaucoma treatment.

“I’ve been surprised how much CBD has taken off and exploded with very little data,” Wasan said. “Most of the other herbal supplements, there are at least some studies on it before it becomes really popular. But for this, I haven’t seen anything.”

The bottom line, researchers said, is that people who want to try CBD for one reason or another should talk with their doctor first. Welty noted that Epidiolex can be put to “off-label” use for other conditions if a doctor feels it might work.

Besides that, consumers might consider buying CBD products from a state-run programme. Some states like Iowa have established such programmes to make CBD available medicinally, Welty said.

“Those products are more reliable, because they have a system to monitor the purity of content,” Welty said. “You’re a little more sure that you’re getting what you’re paying for.”

Many unregulated products

Welty is much less sure of the “artisanal products” containing CBD that are available in stores and dispensaries, and for good reason – studies have shown that most of these products fail tests for content and purity.

A 2017 study concluded that nearly seven of 10 CBD products didn’t contain the amount of cannabidiol promised on the label, according to findings published in the Journal of the American Medical Association.

Nearly 43% of the products contained too little CBD, while about 26% contained too much. Worse, about one in five CBD products contained the intoxicating pot chemical THC.

“The CBD products that come through that route, there’s essentially no control, and you as a consumer have no way to know what you’re getting,” Welty said.

Copenhaver believes other legitimate uses for CBD could be found, but it will require a more extensive knowledge of the way the human body responds to marijuana’s different compounds.

People might do best to wait until the dust settles regarding the medical evidence, rather than being caught up in the CBD craze, Hurd said.

“It’s like we do this every 30 years or so,” Hurd said. “We romanticise something, that this is going to be the cure-all for every disorder. We’ve never found that.”

Image credit: iStock

Share Button

Health24.com | ‘Robopets’ bring companionship and lower stress in nursing homes

Cuddler the bear, Aibo the dog, Justocat the purring kitty: They may only be furry, lifelike robots, but they have a made a real impact in nursing homes.

That’s the finding of new British research that suggests these high-tech “robopets” are the next best thing for nursing home residents unable to have a beloved pet or those suffering from loneliness.

Fond memories

“Although not every … resident may choose to interact with robopets, for those who do, they appear to offer many benefits,” study author Rebecca Abbott, of the University of Exeter Medical School, said in a university news release.

The robopets stimulate conversations and trigger fond memories of pets or past experiences, Abbott said. “And there is also the comfort of touching or interacting with the robopet itself. The joy of having something to care for was a strong finding across many of the studies.”

One US geriatrician who was not involved in the study said engagement with a robotpet does seem helpful.

“Most importantly, it was found to decrease loneliness and increase pleasure and joy, and bring comfort,” said Dr Maria Torroella Carney. She directs geriatrics and palliative medicine at Northwell Health in Great Neck, New York.

In the new study, Abbott’s group analysed data from 19 studies involving 900 nursing home residents, family members and staff at centres worldwide. Five different robopets were used in the studies: Necoro and Justocat (cats); Aibo (a dog); Cuddler (a bear); and Paro (a baby seal).

Many nursing home residents were entertained by the robopet even if they realised it wasn’t a real dog or cat. Of course, “residents’ responses could vary according to whether they were living with dementia and according to the severity of the dementia,” Abbott’s team noted.

Feeling loved

Some residents talked to the robopet as if it were, in fact, alive and a real animal. Some even made an emotional connection with the “pet”. For example, one resident told staff, “I woke up today and thought, today is going to be a good day because I get to see my friend.”

For others, just holding and stroking the robopet brought “them back into a space in their life where they feel loved”, as one nursing home caretaker put it in the study.

As to whether the robopet felt “real”, one resident’s family member said that it “doesn’t matter, because I can see that the robotic cat has an impact on my dad’s quality of life”.

Besides their other benefits, robopets appeared to boost social interaction with other residents, family members and staff, often by acting as a trigger for conversation, according to the research.

Of course, not every nursing home resident was enthused about the robopet. Some ignored them or even reacted negatively, and others were put off by their artificiality.

That means that specific staff training about the best use of the devices should help residents get the most out of the technology, Abbott and colleagues suggested.

For example, knowing if a person likes animals or once had pets is likely to affect how much they engage with a robopet, the team said.

The bottom line is that “it is not always possible to have a cat or a dog come into a care home, so robopets can offer a good alternative”, study co-author Noreen Orr concluded.

Questions remain

“Of course, robopets are no substitute for human interaction,” she said, “but our research shows that for those who choose to engage with them, they can have a range of benefits.”

For her part, Carney said questions remain around the benefits of the technology.

For example, while the emotional benefits for some residents seem clear, “We don’t know if this [technology] decreases medication use or any other health outcomes,” she said. Also, more study is needed into “which population of patients have best engagement and benefit”, Carney said.

And there’s one other drawback, for now: Robopets can be prohibitively expensive. However, “a new wave of more affordable robopets may make them more accessible to care homes,” Orr believes.

The study, which received no private industry funding, was published in the International Journal of Older People Nursing.

Image credit: iStock

Share Button

NHS fines for 1.7 million people overturned, watchdog finds

A watchdog finds £188m incorrect penalties by the NHS in England for dental treatment and prescriptions.

Share Button

A step for a promising new battery to store clean energy

Researchers have built a more efficient, more reliable potassium-oxygen battery, a step toward a potential solution for energy storage on the nation’s power grid and longer-lasting batteries in cell phones and laptops.

In a study published Friday in the journal Batteries and Supercaps, researchers from The Ohio State University detailed their findings centering around the construction of the battery’s cathode, which stores the energy produced by a chemical reaction in a metal-oxygen or metal-air battery. The finding, the researchers say, could make renewable energy sources like solar and wind more viable options for the power grid through cheaper, more efficient energy storage.

“If you want to go to an all-renewable option for the power grid, you need economical energy storage devices that can store excess power and give that power back out when you don’t have the source ready or working,” said Vishnu-Baba Sundaresan, co-author of the study and professor of mechanical and aerospace engineering at Ohio State. “Technology like this is key, because it is cheap, it doesn’t use any exotic materials, and it can be made anywhere and promote the local economy.”

Renewable energy sources don’t emit carbon dioxide, so they don’t contribute to global warming — but they provide energy only when the sun is shining or the wind is blowing. In order for them to be reliable sources of power for a region’s energy grid, there needs to be a way to store excess energy gathered from sunshine and wind.

Companies, scientists and governments around the world are working on storage solutions, ranging from lithium-ion batteries — bigger versions of those in many electric vehicles — to giant batteries the size of a big-box store made using the metal vanadium.

Potassium-oxygen batteries have been a potential alternative for energy storage since they were invented in 2013. A team of researchers from Ohio State, led by chemistry professor Yiying Wu, showed that the batteries could be more efficient than lithium-oxygen batteries while simultaneously storing about twice the energy as existing lithium-ion batteries. But potassium-oxygen batteries have not been widely used for energy storage because, so far, they haven’t been able to recharge enough times to be cost-effective.

As teams tried to create a potassium-oxygen battery that could be a viable storage solution, they kept running into a roadblock: The battery degraded with each charge, never lasting longer than five or 10 charging cycles — far from enough to make the battery a cost-effective solution for storing power. That degradation happened because oxygen crept into the battery’s anode — the place that allows electrons to charge a device, be it a cell phone or a power grid. The oxygen caused the anode to break down, making it so the battery itself could no longer supply a charge.

Paul Gilmore, a doctoral candidate in Sundaresan’s lab, began incorporating polymers into the cathode to see if he might be able to protect the anode from oxygen. If he could find a way to do that, he thought, it would give potassium-oxygen batteries a shot at longer lives. It turned out he was right: The team realized that swelling in the polymer played a vital role in its performance. The key, Gilmore said, was finding a way to bring oxygen into the battery — necessary for it to work — without allowing oxygen to seep into the anode.

This design works a bit like human lungs: Air comes in to the battery through a fibrous carbon layer, then meets a second layer that is slightly less porous and finally ends at a third layer, which is barely porous at all. That third layer, made of the conducting polymer, allows potassium ions to travel throughout the cathode, but restricts molecular oxygen from getting to the anode. The design means that the battery can be charged at least 125 times — giving potassium-oxygen batteries more than 12 times the longevity they previously had with low-cost electrolytes.

The finding shows that this is possible, but the team’s tests haven’t proven that the batteries can be made on the scale necessary for power-grid storage, Sundaresan said. However, it does show potential.

Gilmore said potential may also exist for potassium-oxygen batteries to be useful in other applications.

“Oxygen batteries have higher energy density, which means they can improve the range of electric vehicles and battery life of portable electronics, for example, though other challenges must be overcome before potassium-oxygen batteries are viable for these applications,” he said.

And the finding offers an alternative to lithium-ion batteries and others that rely on cobalt, a material that has been called “the blood diamond of batteries.” The mining of the material is so troubling that major companies, including TESLA, have announced their plans to eliminate it from batteries entirely.

“It is very important that batteries intended for large-scale applications do not use cobalt,” Sundaresan said.

And it is also important that the battery can be made cheaply. Lithium-oxygen batteries — a possible energy storage solution that is widely considered one of the most viable options — can be expensive, and many rely on scarce resources, including cobalt. The lithium-ion batteries that power many electric cars cost around $100 per kilowatt hour at the materials level.

The researchers estimated that this potassium-oxygen battery will cost about $44 per kilowatt hour.

“When it comes to batteries, one size does not fit all,” Sundaresan said. “For potassium-oxygen and lithium-oxygen batteries, the cost has been prohibitive to use them as grid power backup. But now that we’ve shown that we can make a battery this cheap and this stable, then it makes it compete with other technologies for grid power backup.

“If you have a smallish battery that is cheap, then you can talk about scaling it up. If you have a smallish battery that is $1,000 a pop, then scaling it up is just not possible. This opens the door for scaling it up.”

This work was funded by a grant from the National Science Foundation.

Share Button

Measuring chromosome imbalance could clarify cancer prognosis

Most human cells have 23 pairs of chromosomes. Any deviation from this number can be fatal for cells, and several genetic disorders, such as Down syndrome, are caused by abnormal numbers of chromosomes.

For decades, biologists have also known that cancer cells often have too few or too many copies of some chromosomes, a state known as aneuploidy. In a new study of prostate cancer, researchers have found that higher levels of aneuploidy lead to much greater lethality risk among patients.

The findings suggest a possible way to more accurately predict patients’ prognosis, and could be used to alert doctors which patients might need to be treated more aggressively, says Angelika Amon, the Kathleen and Curtis Marble Professor in Cancer Research in the Department of Biology and a member of the Koch Institute for Integrative Cancer Research.

“To me, the exciting opportunity here is the ability to inform treatment, because prostate cancer is such a prevalent cancer,” says Amon, who co-led this study with Lorelei Mucci, an associate professor of epidemiology at the Harvard T.H. Chan School of Public Health.

Konrad Stopsack, a research associate at Memorial Sloan Kettering Cancer Center, is the lead author of the paper, which appears in the Proceedings of the National Academy of Sciences the week of May 13. Charles Whittaker, a Koch Institute research scientist; Travis Gerke, a member of the Moffitt Cancer Center; Massimo Loda, chair of pathology and laboratory medicine at New York Presbyterian/Weill Cornell Medicine; and Philip Kantoff, chair of medicine at Memorial Sloan Kettering; are also authors of the study.

Better predictions

Aneuploidy occurs when cells make errors sorting their chromosomes during cell division. When aneuploidy occurs in embryonic cells, it is almost always fatal to the organism. For human embryos, extra copies of any chromosome are lethal, with the exceptions of chromosome 21, which produces Down syndrome; chromosomes 13 and 18, which lead to developmental disorders known as Patau and Edwards syndromes; and the X and Y sex chromosomes. Extra copies of the sex chromosomes can cause various disorders but are not usually lethal.

Most cancers also show very high prevalence of aneuploidy, which poses a paradox: Why does aneuploidy impair normal cells’ ability to survive, while aneuploid tumor cells are able to grow uncontrollably? There is evidence that aneuploidy makes cancer cells more aggressive, but it has been difficult to definitively demonstrate that link because in most types of cancer nearly all tumors are aneuploid, making it difficult to perform comparisons.

Prostate cancer is an ideal model to explore the link between aneuploidy and cancer aggressiveness, Amon says, because, unlike most other solid tumors, many prostate cancers (25 percent) are not aneuploid or have only a few altered chromosomes. This allows researchers to more easily assess the impact of aneuploidy on cancer progression.

What made the study possible was a collection of prostate tumor samples from the Health Professionals Follow-up Study and Physicians’ Health Study, run by the Harvard T.H. Chan School of Public Health over the course of more than 30 years. The researchers had genetic sequencing information for these samples, as well as data on whether and when their prostate cancer had spread to other organs and whether they had died from the disease.

Led by Stopsack, the researchers came up with a way to calculate the degree of aneuploidy of each sample, by comparing the genetic sequences of those samples with aneuploidy data from prostate genomes in The Cancer Genome Atlas. They could then correlate aneuploidy with patient outcomes, and they found that patients with a higher degree of aneuploidy were five times more likely to die from the disease. This was true even after accounting for differences in Gleason score, a measure of how much the patient’s cells resemble cancer cells or normal cells under a microscope, which is currently used by doctors to determine severity of disease.

The findings suggest that measuring aneuploidy could offer additional information for doctors who are deciding how to treat patients with prostate cancer, Amon says.

“Prostate cancer is terribly overdiagnosed and terribly overtreated,” she says. “So many people have radical prostatectomies, which has significant impact on people’s lives. On the other hand, thousands of men die from prostate cancer every year. Assessing aneuploidy could be an additional way of helping to inform risk stratification and treatment, especially among people who have tumors with high Gleason scores and are therefore at higher risk of dying from their cancer.”

Amon is now working with researchers from the Harvard T.H. Chan School of Public Health to explore whether aneuploidy can be reliably measured from small biopsy samples.

Aneuploidy and cancer aggressiveness

The researchers found that the chromosomes that are most commonly aneuploid in prostate tumors are chromosomes 7 and 8. They are now trying to identify specific genes located on those chromosomes that might help cancer cells to survive and spread, and they are also studying why some prostate cancers have higher levels of aneuploidy than others.

“This research highlights the strengths of interdisciplinary, team science approaches to tackle outstanding questions in prostate cancer,” Mucci says. “We plan to translate these findings clinically in prostate biopsy specimens and experimentally to understand why aneuploidy occurs in prostate tumors.”

Another type of cancer where most patients have low levels of aneuploidy is thyroid cancer, so Amon now hopes to study whether thyroid cancer patients with higher levels of aneuploidy also have higher death rates.

“A very small proportion of thyroid tumors is highly aggressive and lethal, and I’m starting to wonder whether those are the ones that have some aneuploidy,” she says.

The research was funded by the Koch Institute Dana Farber/Harvard Cancer Center Bridge Project and by the National Institutes of Health, including the Koch Institute Support (core) Grant.

Share Button

Flu virus’ best friend: Low humidity

Yale researchers have pinpointed a key reason why people are more likely to get sick and even die from flu during winter months: low humidity.

While experts know that cold temperatures and low humidity promote transmission of the flu virus, less is understood about the effect of decreased humidity on the immune system’s defenses against flu infection.

The Yale research team, led by Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology, explored the question using mice genetically modified to resist viral infection as humans do. The mice were all housed in chambers at the same temperature, but with either low or normal humidity. They were then exposed to the influenza A virus.

The researchers found that low humidity hindered the immune response of the animals in three ways. It prevented cilia, which are hair-like structures in airways cells, from removing viral particles and mucus. It also reduced the ability of airway cells to repair damage caused by the virus in the lungs. The third mechanism involved interferons, or signaling proteins released by virus-infected cells to alert neighboring cells to the viral threat. In the low-humidity environment, this innate immune defense system failed.

The study offers insight into why the flu is more prevalent when the air is dry. “It’s well known that where humidity drops, a spike in flu incidence and mortality occurs. If our findings in mice hold up in humans, our study provides a possible mechanism underlying this seasonal nature of flu disease,” said Iwasaki.

While the researchers emphasized that humidity is not the only factor in flu outbreaks, it is an important one that should be considered during the winter season. Increasing water vapor in the air with humidifiers at home, school, work, and even hospital environments is a potential strategy to reduce flu symptoms and speed recovery, they said.

The study was published in the Proceedings of the National Academy of Sciences (PNAS).

Other authors are Eriko Kudo, Eric Song, Laura Yockey, Tasfia Rakib, Patrick Wong, and Robert Homer.

This work was supported in part by the Howard Hughes Medical Institute, a gift from the Condair Group, the Naito Foundation, and National Institutes of Health grants.

Story Source:

Materials provided by Yale University. Original written by Ziba Kashef. Note: Content may be edited for style and length.

Share Button

Health24.com | Weight before pregnancy most important risk for complications

Expectant mothers and doctors have focused a lot on how much a woman gains during pregnancy, but new research suggests how much a woman weighs before getting pregnant may be far more important.

The study found that the more a woman weighed at the start of her pregnancy, the more likely she was to experience complications such as high blood pressure, preeclampsia, gestational diabetes, Caesarean delivery and preterm birth.

Improving pregnancy outcomes

“Pregnancy complications in mothers and their infants occurred in 34% of women with a normal weight and in over 60% of women with severe obesity at the start of their pregnancy,” said senior author Dr Romy Gaillard. She’s an assistant professor of paediatrics at Erasmus MC University Medical Center in Rotterdam, the Netherlands.

“Rather than focusing on maternal weight gain during pregnancy, strategies are needed to optimise maternal weight before the start of pregnancy to improve pregnancy outcomes,” she said.

That doesn’t mean expectant moms should feel free to “eat for two” throughout pregnancy, however. Weight gain during pregnancy still matters, according to Dr Navid Mootabar, chairman of obstetrics and gynaecology at Northern Westchester Hospital in Mount Kisco, New York.

“The take-home is that if you want a healthy pregnancy, it’s not as much about maintaining the proper weight gain during pregnancy as it is about going into pregnancy with a proper pre-pregnancy weight,” said Mootabar, who reviewed the study’s findings.

Obesity rates have been rising in the United States and other parts of the world. Gaillard said obesity among women of reproductive age is a major problem.

To see what affect weight before and during pregnancy had on pregnancy outcomes, researchers reviewed 25 studies involving almost 200 000 women. Data was collected between 1989 and 2015.

Adverse events

The average age of the women was 30, and they came from Europe and North America.

Researchers categorised the women by weight status using body mass index (BMI). BMI is a rough estimate of how much fat someone has based on height and weight. For example, a 5-foot-5-inch (1.65m) woman who weighs 148 pounds (67kg) has a BMI of 24.6, which is considered normal weight.

About 4% of the women were underweight (BMI under 18.5); 68% were of normal weight (BMI 18.5-24.9); 20% were overweight (BMI 25-29.9); and about 8% were obese (BMI 30 and over).

In the obese category, 6% were considered grade one (BMI 30-34.9); almost 2% were grade two (BMI 35.0-39.9), and 0.5% were grade three (BMI 40 and over).

Just over 37% of pregnancies had an adverse event. Underweight women experienced an adverse event about 35% of the time compared to 61% for women who were obesity grade three.

Gaillard said weight-gain guidelines can be used to counsel women, but aren’t useful for predicting an individual woman’s risk of pregnancy complications.

Pregnancy ‘a marathon’

Dr Jill Rabin is co-chief of the division of ambulatory care, Women’s Health Programs-PCAP Services at Northwell Health in New Hyde Park, New York, and reviewed the study. She noted researchers cited several limitations in the data for weight gain during pregnancy, including self-reported pregnancy weights.

Rabin said the value of the study lies in the focus on pre-pregnancy weight.

“Pregnancy isn’t a sprint, it’s a marathon. What’s important, really, is how are you going into pregnancy? And, it’s not just weight, we need to optimise other metabolic and nutrition factors before conception,” Rabin said.

As far as weight gained during pregnancy, Rabin said that varies by individual. “There’s no one-size-fits-all answer. It really depends on how the baby is growing and how mom is utilising her nutritional input, because everyone utilises calories differently,” she explained.

The biggest problem, Rabin said, is that many women don’t see a doctor for pre-conception planning.

Mootabar agreed that women “need to get in touch with their providers before getting pregnant to discuss their risk factors. What happens now is a lot of women don’t show up to their doctors until after they’re already pregnant.”

The study was published in Journal of the American Medical Association.

Image credit: iStock

NEXT ON HEALTH24X

Share Button